Domestic drugs are taking an active part in PPI drug market

On August 11, according to the analysis result of prescription status of major PPI products in the first half of the year, domestic development PPI products ranked from no.3 to no.7.

Esomezol capsule which is an incrementally modified drug of Nexium ranked no.3 and recorded 21% growth in the first half of this year. It was recently launched in the U.S. and the patent of original drug Nexium wa...